Why is RPG Life Sciences Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.70% over the last 5 years
2
Flat results in Mar 26
- ROCE(HY) Lowest at 24.18%
- PBT LESS OI(Q) At Rs 26.74 cr has Fallen at -9.3% (vs previous 4Q average)
3
Despite the size of the company, domestic mutual funds hold only 0.15% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
How much should you hold?
- Overall Portfolio exposure to RPG LifeScience. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RPG LifeScience. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
RPG LifeScience.
14.62%
0.09
37.21%
Sensex
-3.01%
-0.49
12.94%
Quality key factors
Factor
Value
Sales Growth (5y)
12.60%
EBIT Growth (5y)
17.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
1.53
Tax Ratio
25.33%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
9.63%
ROCE (avg)
41.11%
ROE (avg)
20.40%
Valuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
37
Price to Book Value
7.21
EV to EBIT
31.14
EV to EBITDA
26.68
EV to Capital Employed
10.77
EV to Sales
5.64
PEG Ratio
1.62
Dividend Yield
0.91%
ROCE (Latest)
32.66%
ROE (Latest)
19.27%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Movement
11What is working for the Company
PAT(Q)
Highest at Rs 30.76 cr.
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 156.78 cr
NET SALES(Q)
Highest at Rs 195.69 cr
PBDIT(Q)
Highest at Rs 43.29 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 22.12%
PBT LESS OI(Q)
Highest at Rs 36.76 cr.
-3What is not working for the Company
ROCE(HY)
Lowest at 24.18%
Loading Valuation Snapshot...
Here's what is working for RPG LifeScience.
Profit After Tax (PAT) - Quarterly
Highest at Rs 30.76 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 195.69 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 43.29 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 22.12%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 36.76 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 156.78 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents